← Open Payments lookup

LINDSEY WEISS: Open Payments

NPI 1265930507 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,594 in 90 payments from 20 companies in 2025. Trend: 2023 $577 · 2024 $474 · 2025 $3,594

Food & beverage: $2,274Consulting: $960Travel & lodging: $360
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.16$1,766
ABBVIE INC.10$213
GENZYME CORPORATION9$212
PFIZER INC.11$207
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$192
Janssen Scientific Affairs, LLC3$182
Janssen Biotech, Inc.7$152
Ardelyx, Inc.3$142
Lilly USA, LLC4$84
Intercept Pharmaceuticals, Inc.3$76

Products named: ENTYVIO, TREMFYA, DUPIXENT, XIFAXAN, XELJANZ, IBSRELA, RINVOQ, OMVOH.

Industry payments across MD — which companies pay providers there.